Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Caraco Pharma has reported net sales of $97.79m for the second quarter ended 30 September 2010, compared to $78.38m for the same period in 2009.
Subscribe to our email newsletter
Caraco Pharma has posted a net loss of $1.51m for the second quarter 2010, or $0.04 loss per diluted share, compared to net income of $6.67m, or $0.16 per diluted share, for the comparable period in 2009.
Operating loss was $2.45m, compared to operating income of $10.56m for the comparable period in 2009.
For the six months ended 30 September 2010, Caraco Pharma has posted net sales of $227.82m, compared to $126.45m for the year ago period.
Net loss was $298,048, or $0.01 loss per diluted share for the six months ended 30 September 2010, compared to $2.75m, or $0.07loss per diluted share, for the year ago period.
Operating loss was 867,821, compared to $3.79m for the year ago period.
Detroit-based Caraco Pharma manufactures, develops, markets and distributes generic pharmaceuticals to wholesalers, distributors, drugstore chains and managed care providers.